VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $63,280,000 | -11.1% | 354,750 | +10.7% | 6.71% | +99.3% |
| Q2 2015 | $71,166,000 | +17.5% | 320,350 | +5.1% | 3.36% | -6.8% |
| Q1 2015 | $60,569,000 | +746.4% | 304,950 | +509.9% | 3.61% | +607.8% |
| Q4 2014 | $7,156,000 | -45.5% | 50,000 | -50.0% | 0.51% | -55.5% |
| Q3 2014 | $13,120,000 | +31.0% | 100,001 | +31.6% | 1.15% | -3.8% |
| Q1 2014 | $10,019,000 | – | 76,000 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |